David Vogel

472 total citations
9 papers, 344 citations indexed

About

David Vogel is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, David Vogel has authored 9 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in David Vogel's work include interferon and immune responses (3 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Advanced Biosensing Techniques and Applications (1 paper). David Vogel is often cited by papers focused on interferon and immune responses (3 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Advanced Biosensing Techniques and Applications (1 paper). David Vogel collaborates with scholars based in United States, Taiwan and Canada. David Vogel's co-authors include Ed Croze, Sharlene Velichko, Sandra L. Biroc, David R. Light, M.R. Sandhya Rani, H. Daniel Perez, Stewart Leung, Richard M. Ransohoff, Harald Dinter and Renate Parry and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and International Journal of Cancer.

In The Last Decade

David Vogel

9 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Vogel United States 8 127 101 86 50 48 9 344
Sang-Chul Park South Korea 11 95 0.7× 31 0.3× 128 1.5× 16 0.3× 32 0.7× 48 431
Muhammad Farooq Pakistan 15 25 0.2× 108 1.1× 150 1.7× 49 1.0× 46 1.0× 51 585
Hideki Kanda Japan 15 114 0.9× 22 0.2× 169 2.0× 88 1.8× 6 0.1× 73 693
Ruth Dukes United Kingdom 11 51 0.4× 53 0.5× 23 0.3× 26 0.5× 12 0.3× 47 359
John R. Wells United States 14 53 0.4× 27 0.3× 220 2.6× 29 0.6× 9 0.2× 42 700
Masayoshi Noguchi Japan 14 79 0.6× 47 0.5× 216 2.5× 12 0.2× 4 0.1× 94 736
Francesco Rotondo Italy 10 66 0.5× 32 0.3× 62 0.7× 13 0.3× 9 0.2× 25 335
Andreas Schröer Germany 12 29 0.2× 48 0.5× 112 1.3× 37 0.7× 8 0.2× 47 832
Joanne Ho United States 11 51 0.4× 10 0.1× 173 2.0× 145 2.9× 33 0.7× 19 562

Countries citing papers authored by David Vogel

Since Specialization
Citations

This map shows the geographic impact of David Vogel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Vogel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Vogel more than expected).

Fields of papers citing papers by David Vogel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Vogel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Vogel. The network helps show where David Vogel may publish in the future.

Co-authorship network of co-authors of David Vogel

This figure shows the co-authorship network connecting the top 25 collaborators of David Vogel. A scholar is included among the top collaborators of David Vogel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Vogel. David Vogel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Liang, Amy, Emmanuel Claret, David Vogel, et al.. (2007). Development of a Homogeneous Time-Resolved Fluorescence Leukotriene B4 Assay for Determining the Activity of Leukotriene A4 Hydrolase. SLAS DISCOVERY. 12(4). 536–545. 7 indexed citations
2.
Satozawa, Noboru, Kirk Mclean, David Vogel, et al.. (2006). Obligate Multivalent Recognition of Cell Surface Tomoregulin following Selection from a Multivalent Phage Antibody Library. SLAS DISCOVERY. 11(8). 985–995. 7 indexed citations
3.
Schneider, Doug, Alicia Newton, Ying Zhu, et al.. (2006). Antibodies Neutralizing Hepsin Protease Activity Do Not Impact Cell Growth but Inhibit Invasion of Prostate and Ovarian Tumor Cells in Culture. Cancer Research. 66(7). 3611–3619. 60 indexed citations
4.
Zhang, Jianhua, Cynthia Gross, Wei Xia, et al.. (2006). Anti-EphA2 Antibodies Decrease EphA2 Protein Levels in Murine CT26 Colorectal and Human MDA-231 Breast Tumors But Do Not Inhibit Tumor Growth. Neoplasia. 8(1). 18–30. 32 indexed citations
5.
Velichko, Sharlene, et al.. (2004). Interferon receptor expression regulates the antiproliferative effects of interferons on cancer cells and solid tumors. International Journal of Cancer. 111(1). 32–42. 59 indexed citations
6.
Vogel, David. (2004). FROM THE EDITOR. California Management Review. 47(1). 1 indexed citations
7.
Velichko, Sharlene, David Vogel, M.R. Sandhya Rani, et al.. (2002). Interferon Signaling Is Dependent on Specific Tyrosines Located within the Intracellular Domain of IFNAR2c. Journal of Biological Chemistry. 277(2). 1493–1499. 40 indexed citations
8.
Rani, M.R. Sandhya, David Vogel, Oscar R. Colamonici, et al.. (2000). Role of the Intracellular Domain of the Human Type I Interferon Receptor 2 Chain (IFNAR2c) in Interferon Signaling. Journal of Biological Chemistry. 275(31). 23981–23985. 15 indexed citations
9.
Vogel, David. (1997). Trading Up. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026